SCHEMBL7480804

SCHEMBL7480804

NC(=O)C=Cc1ccc(Br)cc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.51
GPR183 P32249 2/20 0.49
MIF P14174 1/20 0.47
CCNC P24863 1/20 0.45
CDK8 P49336 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
PELI1 Q96FA3 1/20 0.42
CYP1A1 P04798 1/20 0.39
CYP1B1 Q16678 1/20 0.39
MAPT P10636 3/20 0.38
NPC1 O15118 2/20 0.38
ALDH1A1 P00352 2/20 0.38
RAB9A P51151 2/20 0.38
LMNA P02545 1/20 0.38
NTSR1 P30989 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
AR P10275 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30632952 1.00 DGAT1 (0.51) DGAT1GPR183MIFCCNCCDK8
SCHEMBL22397868 1.00 DGAT1 (0.51) DGAT1GPR183MIFCCNCCDK8
SCHEMBL1469977 0.84 MIF (0.67) DGAT1GPR183MIFSMN1; SMN2CYP1A1
SCHEMBL1469976 0.84 MIF (0.67) DGAT1GPR183MIFSMN1; SMN2CYP1A1
SCHEMBL3170968 0.84 DGAT1 (0.56) DGAT1GPR183SMN1; SMN2MAPTNPC1
Hydrochloric Acid SCHEMBL6818301 0.83 MIF (0.65) DGAT1GPR183MIFSMN1; SMN2CYP1A1
SCHEMBL6818296 0.83 GPR183 (0.49) DGAT1GPR183MIFSMN1; SMN2CYP1A1
SCHEMBL1572450 0.83 GPR183 (0.49) DGAT1GPR183MIFSMN1; SMN2CYP1A1
SCHEMBL5751280 0.82 CYP1A1 (0.55) MIFPELI1CYP1A1CYP1B1
SCHEMBL5751272 0.82 CYP1A1 (0.55) MIFPELI1CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222172-A1 SYNTHESIS OF 1,3,5-TRISUBSTITUTED PYRAZOLES AND INTERMEDIATES THEREFORE Bristol-Myers Squibb Pharma Company (US) 2002-07-17 EP disclosed
WO-2001029006-A1 SYNTHESIS OF 1,3,5-TRISUBSTITUTED PYRAZOLES AND INTERMEDIATES THEREFORE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-04-26 WO disclosed